Recombinant human insulin-like growth factor-I in ALS: Description of a double-blind, placebo-controlled study

D. J. Lange, K. J. Felice, B. W. Festoff, M. J. Gawel, D. F. Gelinas, R. Kratz, E. C. Lai, M. F. Murphy, H. M. Natter, F. H. Norris, S. Rudnicki

Research output: Contribution to journalArticle

49 Scopus citations

Fingerprint Dive into the research topics of 'Recombinant human insulin-like growth factor-I in ALS: Description of a double-blind, placebo-controlled study'. Together they form a unique fingerprint.